2018
DOI: 10.1016/j.euroneuro.2018.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
24
1
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(29 citation statements)
references
References 79 publications
1
24
1
1
Order By: Relevance
“…Given evidence implicating FAAH in the pathogenesis of PTSD [ 56 ] and the high rate of comorbidity between PTSD and BPD, we used MANCOVA to test the effect of comorbid PTSD on PFC and amygdala [ 11 C]CURB λ k 3 . Twenty percent of the BPD sample screened positive for current PTSD (Supplementary Table 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…Given evidence implicating FAAH in the pathogenesis of PTSD [ 56 ] and the high rate of comorbidity between PTSD and BPD, we used MANCOVA to test the effect of comorbid PTSD on PFC and amygdala [ 11 C]CURB λ k 3 . Twenty percent of the BPD sample screened positive for current PTSD (Supplementary Table 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…This showed that kaempferol ameliorated the memory reconsolidation as well as facilitated the extinction in treated groups at the given doses. Although not significantly different from standard FAAH inhibitor URB, which has been previously reported to reduce contextual fear-related freezing behavior [ 47 ], the reduction in freezing behavior with kaempferol was higher ( Figure 2 a). Thus, Kaempferol mediated FAAH inhibition impaired premature amalgamation of contextual fear conditioning 48 but also enhanced the extinction of conditioned fear-related aversive memories [ 48 ].…”
Section: Discussionmentioning
confidence: 54%
“…concomitantly with URB597 administration to determine whether URB597 behavioral effects were mediated by CB1 receptors ( Figure 1A ). This AM251 dose was chosen because it is low enough to avoid the induction of behavioral effects per se but effective in preventing the stimulation of CB1 receptors ( Fidelman et al, 2018 ).…”
Section: Methodsmentioning
confidence: 99%